It is a rare benign tumour of mesenchymal origin and known to occur in the genital regions of both genders predominantly affecting the vulva of middle aged females and inguinal region of elderly males (2).
The findings by experts from the Massachusetts Institute of Technology suggested that drugs that restore p53 function could help prevent aggressive lung cancers from metastasising, though they might spare benign tumour cells that could later turn aggressive.